Abstract
Oral premalignant disorders (OPMD) have relatively high malignant transformation rates to Oral Cancers (OC). Oral carcinogenesis is a multistep process that originates as epithelial hyperplasia followed by epithelial dysplasia, leading to fully malignant phenotypes. Early detection can be lifesaving but is currently not possible due to the lack of early diagnostic tools. The current diagnostic methods such as biopsy sampling, tumor tissue staining, and imaging techniques require skilled personnel and are invasive, painful, time-consuming, and expensive. Saliva has gained momentum as the diagnostic fluid of the future due to its noninvasive nature, ease of sampling, multiple samples can be collected with ease and more importantly does not require skilled personnel. The use of saliva in cancer diagnostics is an emerging and an expanding field. MicroRNA (miRNA) play a role in cancer initiation and progression and the expression changes of miRNA have been investigated as a potential biomarker in cancer studies. In this chapter, we describe a robust and cost-effective protocol to isolate and enrich miRNA from saliva samples. Profiling miRNAs in saliva samples can form part of the clinical management of OPMD and OC patients in the future.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Huber MA, Tantiwongkosi B (2014) Oral and oropharyngeal cancer. Med Clin North Am 98(6):1299. https://doi.org/10.1016/j.mcna.2014.08.005
Greer RO Jr (2011) Oral manifestations of smokeless tobacco use. Otolaryngol Clin North Am 44(1):31–56, v. https://doi.org/10.1016/j.otc.2010.09.002
Sharan RN, Mehrotra R, Choudhury Y, Asotra K (2012) Association of betel nut with carcinogenesis: revisit with a clinical perspective. PLoS One 7(8):e42759. https://doi.org/10.1371/journal.pone.0042759
van der Waal I (2009) Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45(4–5):317–323. https://doi.org/10.1016/j.oraloncology.2008.05.016
van der Waal I (2010) Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol 46(6):423–425. https://doi.org/10.1016/j.oraloncology.2010.02.016
Yardimci G, Kutlubay Z, Engin B, Tuzun Y (2014) Precancerous lesions of oral mucosa. World J Clin Cases 2(12):866–872. https://doi.org/10.12998/wjcc.v2.i12.866
Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29. https://doi.org/10.3322/caac.21208
Salazar C, Calvopiña D, Punyadeera C (2014) miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas. Expert Rev Mol Diagn 14(8):1033–1040
Messadi DV (2013) Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci 5(2):59–65. https://doi.org/10.1038/ijos.2013.24
Gillenwater A, Papadimitrakopoulou V, Richards-Kortum R (2006) Oral premalignancy: new methods of detection and treatment. Curr Oncol Rep 8(2):146–154
Zhang X, Schulz B, Walsh T, Atherton J, Kostner K, Punyadeera C (2017) Saliva: linking oral health with heart failure. Eur J Heart Fail 19(S1):1. https://doi.org/10.1002/ejhf.833
Cheng Y-SL, Rees T, Wright J (2014) A review of research on salivary biomarkers for oral cancer detection. Clin Transl Med 3:3–3. https://doi.org/10.1186/2001-1326-3-3
Kaufman E, Lamster IB (2002) The diagnostic applications of saliva—a review. Crit Rev Oral Biol Med 13(2):197–212
Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C (2011) Diagnostic potential of saliva: current state and future applications. Clin Chem 57(5):675–687
Zhang X, Walsh T, Atherton JJ, Kostner K, Schulz B, Punyadeera C (2017) Identification and validation of a salivary protein panel to detect heart failure early. Theranostics 7(18):4350–4358. https://doi.org/10.7150/thno.21727
Punyadeera C, Dimeski G, Kostner K, Beyerlein P, Cooper-White J (2011) One-step homogeneous C-reactive protein assay for saliva. J Immunol Methods 373(1–2):19–25. https://doi.org/10.1016/j.jim.2011.07.013
Foo JYY, Wan Y, Kostner K, Arivalagan A, Atherton J, Cooper-White J et al (2012) NT-ProBNP levels in saliva and its clinical relevance to heart failure. PLoS One 7(10):e48452. https://doi.org/10.1371/journal.pone.0048452
Lim Y, Wan Y, Vagenas D, Ovchinnikov DA, Perry CF, Davis MJ et al (2016) Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers. BMC Cancer 16(1):749. https://doi.org/10.1186/s12885-016-2785-0
Chai RC, Lim Y, Frazer IH, Wan Y, Perry C, Jones L et al (2016) A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients. BMC Cancer 16:178. https://doi.org/10.1186/s12885-016-2217-1
Wan Y, Vagenas D, Salazar C, Kenny L, Perry C, Calvopiña D et al (2017) Salivary miRNA panel to detect HPV-positive and HPV-negative head and neck cancer patients. Oncotarget 8(59):99990–100001. https://doi.org/10.18632/oncotarget.21725
Tang KD, Kenny L, Perry C, Frazer I, Punyadeera C (2017) The overexpression of salivary cytokeratins as potential diagnostic biomarkers in head and neck squamous cell carcinomas. Oncotarget 8(42):72272–72280. https://doi.org/10.18632/oncotarget.19731
Zanotti L, Paderno A, Piazza C, Pagan E, Bignotti E, Romani C et al (2017) Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer. Laryngoscope 127(11):E408–e414. https://doi.org/10.1002/lary.26797
Nagler RM (2009) Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol 45(12):1006–1010. https://doi.org/10.1016/j.oraloncology.2009.07.005
Zahran F, Ghalwash D, Shaker O, Al-Johani K, Scully C (2015) Salivary microRNAs in oral cancer. Oral Dis 21(6):739–747
Shiiba M, Uzawa K, Tanzawa H (2010) MicroRNAs in head and neck squamous cell carcinoma (HNSCC) and oral squamous cell carcinoma (OSCC). Cancers 2(2):653–669. https://doi.org/10.3390/cancers2020653
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834. https://doi.org/10.1038/nature03702. https://www.nature.com/articles/nature03702#supplementary-information
Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A, Petrocca F et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103(7):2257–2261
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105(30):10513–10518
Nagadia R, Pandit P, Coman WB, Cooper-White J, Punyadeera C (2013) miRNAs in head and neck cancer revisited. Cell Oncol 36(1):1–7
Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6(6):590–610. https://doi.org/10.1016/j.molonc.2012.09.006
Lin S, Gregory RI (2015) MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 15(6):321
Peng Y, Croce CM (2016) The role of MicroRNAs in human cancer. Signal Transduct Target Ther 1:15004. https://doi.org/10.1038/sigtrans.2015.4
Sethi N, Wright A, Wood H, Rabbitts P (2014) MicroRNAs and head and neck cancer: reviewing the first decade of research. Eur J Cancer 50(15):2619–2635. https://doi.org/10.1016/j.ejca.2014.07.012
Mohamed R, Campbell J-L, Cooper-White J, Dimeski G, Punyadeera C (2012) The impact of saliva collection and processing methods on CRP, IgE, and Myoglobin immunoassays. Clin Transl Med 1:19–19. https://doi.org/10.1186/2001-1326-1-19
Salazar C, Nagadia R, Pandit P, Cooper-White J, Banerjee N, Dimitrova N et al (2014) A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Cell Oncol 37(5):331–338
Acknowledgments
Our work was supported by the Janssen: Pharmaceutical Companies of Johnson & Johnson and Translational Research Institute (TRI) Spore Grant.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Arunachalam, S.R., Tang, K.D., Punyadeera, C. (2019). Isolation and Quantification of MicroRNAs from Human Saliva. In: Batra, J., Srinivasan, S. (eds) Theranostics. Methods in Molecular Biology, vol 2054. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9769-5_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9769-5_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9768-8
Online ISBN: 978-1-4939-9769-5
eBook Packages: Springer Protocols